Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Enlitic

Explore full profile

A modern machine learning company dedicated to revolutionizing diagnostic healthcare

Loveland, United StatesFounded 2014Biotech & Life Sciences
Valuation $100M Market cap · 2019
Revenue $3.8M Latest reported FY
Total funding $50–100M Disclosed equity funding

About Enlitic

Enlitic is a technology company specializing in artificial intelligence (AI) solutions for the healthcare industry. The company develops both clinical and non-clinical AI-powered workflow solutions aimed at enterprise health systems. Enlitic's core product, Curie, is a platform that standardizes data and integrates seamlessly into existing health system infrastructures. This platform provides a range of AI-powered solutions for reading, reporting, quality assurance (QA), and research, thereby simplifying data and improving integration.

Read full description

Enlitic's technology is designed to enhance the workflow, efficiency, and quality of medical diagnostics at scale. Their models can perform post-read analyses, checking radiology reports against corresponding images to help prevent over or under-called findings. The platform supports healthcare professionals by detecting rare and subtle findings, providing measurements and descriptions, automating longitudinal analysis, and generating reports.

The company primarily serves enterprise health systems, offering solutions that address high-value clinical and operational challenges. Enlitic operates in the healthcare technology market, focusing on improving patient outcomes through advanced diagnostics. The business model revolves around providing AI-powered tools that integrate into various stages of the radiological workflow, thereby enhancing the capabilities of healthcare professionals.

Enlitic generates revenue through the sale and licensing of its AI-powered platform and solutions to healthcare providers and enterprise health systems. By continuously improving its products and services through a Quality Management System framework, Enlitic aims to stay at the forefront of healthcare technology.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2014
Headquarters
Loveland, United States
Listing
IPO 2024
Employees
32
Open positions
None listed
Dealroom signal
63.0/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences
Technology
Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Deep Learning, Nanotech, Natural Language Processing, Computer Vision, Recognition Technology
Business model
SaaS
Client focus
b2b
Investment activity
1 company, latest Aug 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITYOther financing Jul 2026 $9.7M — Undisclosed ↗
POST IPO EQUITYOther financing Jul 2025 $2M — GE Healthcare ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026 $3.8M 0%
2025 $3.8M +251.9%
2024 $1.1M +129.4%
2023 $470K -47.9%
2022 $903K -86.1%
2021 $6.5M +32.7%
2020 $4.9M —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Enlitic website traffic

Latest recorded traffic for Enlitic is 9.3K monthly website visits, up 24% over the last three months. Enlitic's team declined 25.6% over the past year.

Latest monthly visits9.3K 3-month web change+24% 1-year team growth-25.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A5 investors entered at this stage

  • Capitol Health
  • Marubeni
  • Thorney Investment
  • Thorney Investment Group
  • Regal Funds Management

Series B and later1 investor entered at this stage

  • GE Healthcare

Other known investors4 additional known investors

  • Alium Capital Management
  • Matt Abrams
  • Mission and Market
  • Sunil Dhaliwal
Team profiled 24 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States56.7%
🇨🇦 Canada23.3%
🇦🇺 Australia13.3%
🇪🇪 Estonia3.3%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Enlitic on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enlitic’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.